Influence of parasellar extension of macroprolactinomas defined by magnetic resonance imaging on their responsiveness to dopamine agonist therapy

Clinical Endocrinology

Volumn 64, Issue 4, 2006, Pages 456-462

  Delgrange, Etienne ^a,c   Duprez, Thierry ^b   Maiter, Dominique ^b  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HORMONE RESISTANCE; HUMAN; INTERNAL CAROTID ARTERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTINOMA; RETROSPECTIVE STUDY; TEACHING HOSPITAL;

ADULT; CAROTID ARTERY, INTERNAL; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RETROSPECTIVE STUDIES; SPHENOID SINUS; TREATMENT OUTCOME;

EID: 33644904601     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02493.x     Document Type: Article

References (25)

1. Ahmadi J. North C.M. Segall H.D. Zee C.S. Weiss M.H. 1986 Cavernous sinus invasion by pituitary adenomas American Journal of Roentgenology 146 257 262
2. Falbusch R. Buchfelder M. 1988 Transsphenoidal surgery of parasellar pituitary adenomas Acta Neurochirurgica (Wien) 92 93 99
3. Knosp E. Steiner E. Kitz K. Matula C. 1993 Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings Neurosurgery 33 610 618
4. Cottier J.P. Destrieux C. Brunereau L. Bertrand P. Moreau L. Jan M. Herbreteau D. 2000 Cavernous sinus invasion by pituitary adenoma: MR imaging Radiology 215 463 469
5. Doniack I. 1992 Pituitary carcinoma Clinical Endocrinology 37 194 195
6. Kaltsas G.A. Nomikos P. Kontogeorgos G. Buchfelder M. Grossman A.B. 2005 Diagnosis and management of pituitary carcinomas Journal of Clinical Endocrinology and Metabolism 90 3089 3099
7. Saeki N. Iuchi T. Isono S. Eda M. Yamaura A. 1999 MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels Neuroradiology 41 765 771
8. Delgrange E. Sassolas G. Perrin G. Jan M. Trouillas J. 2005 Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance Acta Neurochirurgica (Wien) 147 751 758
9. Pan L. Chen Z. Liu Y. Zhao J. 2005 Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space Journal of Neuro-Oncology 74 71 76
10. Losa M. Martini P. Barzaghi R. Gioia L. Giovanelli M. 2002 Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome Journal of Clinical Endocrinology and Metabolism 87 3180 3186
11. Verhelst J. Abs R. Maiter D. Van Den Bruel A. Vandeweghe M. Velkeniers B. Mockel J. Lamberigts G. Petrossians P. Coremans P. Mahler C. Stevenaert A. Verlooy J. Raftopoulos C. Beckers A. 1999 Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients Journal of Clinical Endocrinology and Metabolism 84 2518 2522
12. Delgrange E. Maiter D. Donckier J. 1996 Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine European Journal of Endocrinology 134 454 456
13. Di Sarno A. Landi M.L. Cappabianca P. Di Salle F. Rossi F.W. Pivonello R. Di Somma C. Faggiano A. Lombardi G. Colao A. 2001 Resistance to carbergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy Journal of Clinical Endocrinology and Metabolism 86 5256 5261
14. Therasse P. Arbuck S.G. Eisenhauer E.A. Wanders J. Kaplan R.S. Rubinstein L. Verweij J. Van Glabbeke M. van Oosterom A.T. Christian M.C. Gwyther S.G. 2000 New guidelines to evaluate the response to treatment in solid tumors Journal of the National Cancer Institute 92 205 216
15. Gandour-Edwards R. Kapadia S.B. Janecka I.P. Martinez A.J. Barnes L. 1995 Biologic markers of invasive pituitary adenomas involving the sphenoid sinus Modern Pathology 8 160 164
16. Jaffrain-Rea M.L. Di Stefano D. Minniti G. Esposito V. Bultrini A. Ferretti E. Santoro A. Faticanti Scucchi L. Gulino A. Cantore G. 2002 A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas Endocrine-Related Cancer 9 103 113
17. Corsello S.M. Ubertini G. Altomare M. Lovicu R.M. Migneco M.G. Rota C.A. Colosimo C. 2003 Giant prolactinomas in men: efficacy of cabergoline treatment Clinical Endocrinology 58 662 670
18. Colao A. Di Sarno A. Cappabianca P. Di Somma C. Pivonello R. Lombardi G. 2003 Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia New England Journal of Medicine 349 2023 2033
19. Brue T. Pellegrini I. Priou A. Morange I. Jaquet P. 1992 Prolactinomas and resistance to dopamine agonists Hormone Research 38 84 89
20. Delgrange E. Trouillas J. Maiter D. Donckier J. Tourniaire J. 1997 Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study Journal of Clinical Endocrinology and Metabolism 82 2102 2107
21. Colao A. Vitale G. Cappabianca P. Briganti F. Ciccarelli A. De Rosa M. Zarrilli S. Lombardi G. 2004 Outcome of cabergoline treatment in men with prolactinoma: effects of 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis Journal of Clinical Endocrinology and Metabolism 89 1704 1711
22. Pellegrini I. Rasolonjanahary R. Gunz G. Bertrand P. Delivet S. Jedynak C.P. Kordon C. Peillon F. Jaquet P. Enjalbert A. 1989 Resistance to bromocriptine in prolactinomas Journal of Clinical Endocrinology and Metabolism 69 500 509
23. Caccavelli L. Cussac D. Pellegrini I. Audinot V. Jaquet P. Enjalbert A. 1992 D2 dopaminergic receptors: normal and abnormal transduction mechanisms Hormone Research 38 78 83
24. Hofland L.J. Lamberts S.W. 2004 Somatostatin receptors in pituitary function, diagnosis and therapy Frontiers of Hormone Research 32 235 252
25. Ren S.G. Kim S. Taylor J. Dong J. Moreau J.P. Culler M.D. Melmed S. 2003 Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand Journal of Clinical Endocrinology and Metabolism 88 5414 5421